Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

16. Avril 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1932


	Articles 1 - 20 / 38629

	Prognostic impact of treatment modalities and examined lymph nodes count on survival in T3-4 esophageal cancer: a retrospective cohort and predictive modeling study from the Surveillance, Epidemiology, and End Results database. J Thorac Dis Wu Y, Shi P, Yang P, Yang T, Zhang J, Li S, Feng L, Zhu B, Wu Z. PMID: 41988283 [PubMed]
	The central regulator HIF-1Î± in digestive system pathologies: inflammation and cancer. Front Immunol Gou G, Wen M, Li G, Shu F, Wang F, Liu Y, Xie R, Xu J. PMID: 41988193 [PubMed - indexed for MEDLINE]
	Retrospective analysis of postoperative adjuvant therapy and survival in T4 esophageal squamous cell carcinoma: a dual-cohort study using SEER and Chinese multicenter data. Front Med (Lausanne) Xu ZC, Li JC. PMID: 41987784 [PubMed]
	Cost-effectiveness of pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma. Hum Vaccin Immunother Yu K, Xu Q. PMID: 41987583 [PubMed - indexed for MEDLINE]
	[Esophagobronchial fistula]. Rev Med Liege Rouffignon P, Herman L, Fievet F. PMID: 41987539 [PubMed - indexed for MEDLINE]
	Esophageal cancer: from pathogenesis to precision therapies. Signal Transduct Target Ther Zhang S, Shen Y, Zhu L, Lai Y, Zhu L, Xiao X, Li J, Tan W, Lin D, Wu C. PMID: 41986343 [PubMed - indexed for MEDLINE]
	Lifestyle and Environmental Risk Factors for Esophageal Squamous Cell Carcinoma: Evidence From the Johannesburg Cancer Study. JCO Glob Oncol Chen WC, Bradshaw D, Ramaliba T, Babb de Villiers C, Newton R, Waterboer T, Mathew CG, Muchengeti M, Sitas F. PMID: 41985117 [PubMed - indexed for MEDLINE]
	Surgical approaches to esophageal cancer gastrointestinal reconstruction: a systematic review of jejunum, colon, and ileocolonic interposition with comparative outcome analysis. World J Surg Oncol Liu X, Dai J, Yin M, Zhang R, Song Y. PMID: 41981663 [PubMed - as supplied by publisher]
	Comparison of overall survival across treatment modalities for oesophageal, gastroesophageal, and gastric cancer: protocol for a systematic review and network meta-analysis. Syst Rev Apostolidou-Kiouti F, Haidich AB, Mavridis D, Apostolaki AI, Tsavdaris D, Nikolakopoulou A. PMID: 41981647 [PubMed - as supplied by publisher]
	Global burden of esophageal cancer attributable to smoking and alcohol, 1990-2021, with projections to 2040: a population-based analysis of the global burden of disease study 2021. Ann Med Zhou H, Wu J, Yin Y. PMID: 41980036 [PubMed - indexed for MEDLINE]
	Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study. Ann Surg Oncol Sugase T, Kanemura T, Matsuura N, Yamamoto K, Ushimaru Y, Masuike Y, Yanagimoto Y, Yamamoto K, Sakano Y, Mori R, Kitakaze M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Gotoh K, Kobayashi S, Miyata H. PMID: 41979848 [PubMed - as supplied by publisher]
	Computational-based integrative methylome-transcriptome analysis reveals widespread enhancer hypomethylation in esophageal carcinoma. Epigenomics Ali A, Din TADAAT, Jalal MIA, Arifin WN, Abusalah MAHA, Abuarqoub AH, Ahmed N. PMID: 41979132 [PubMed - as supplied by publisher]
	Impact of adjuvant therapy on survival in esophageal cancer patients after neoadjuvant therapy investigated by a population based cohort study. Sci Rep Huang JL, Lin ZX, Zeng KY, Lu Z, Lin XP, Wang HR, Xie YW, Yang JR. PMID: 41974750 [PubMed - as supplied by publisher]
	Identification of a Novel Disulfidptosis-Related Five-Gene Signature for Prognostic Prediction and Immune Characterization in Esophageal Cancer. Biology (Basel) Chen Y, Li X, Jiang H, Liu X, Ma N, Wang X. PMID: 41972548 [PubMed]
	Immune Evasion of Helicobacter pylori and Extra-Gastric Cancer Risk. J Gastroenterol Hepatol Engin ED, Engin AB, Engin A. PMID: 41972361 [PubMed - as supplied by publisher]
	The construction of CD8+ T cell-associated molecular subtypes in esophageal squamous cell carcinoma reveals tumor heterogeneity, tumor microenvironment, and immunotherapy. Front Immunol Cao S, Jiang H, Li Y, Yang K, Tian L, Li L. PMID: 41972154 [PubMed - indexed for MEDLINE]
	Survival benefit and dynamics of CD8(+) T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy vs. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study. Front Immunol Gan Y, Li Y, Fang L, Chen Y, Yang D. PMID: 41972149 [PubMed - indexed for MEDLINE]
	Prognostic prediction in nasopharyngeal carcinoma using multi-region interaction features based on MRI habitat analysis. Quant Imaging Med Surg Liu P, Li H, Chen S, Chen S, Zhou H, Ruan G, Luo M, Liu L, Chen H. PMID: 41972088 [PubMed]
	Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma. Comput Struct Biotechnol J Nojima Y, Shiratori F, Suzuki T, Yajima S, Toyozumi T, Shimada H. PMID: 41971943 [PubMed]
	Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging. BMJ Oncol Shahraz S, Wong OY, Chotai R, Knight S, Globe D, Patel MJ, Kaushik A, Aiyegbusi OL, Calvert M. PMID: 41971155 [PubMed]

Articles 1 - 20 / 38629

Page 1 de 1932



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité